
Recently, discovery and identification of critical molecules responsible for cancer progression lead to development of specific zzso therapies, including zzso zzso and small molecular zzso For the past 15 years, the advent of zzso zzso has remarkably improved the clinical outcomes of certain patients with various zzso and it was followed by the understanding of mechanism of the drug zzso Moreover, useful zzso were developed to further increase the power of patient selection for zzso zzso From the historical point of view, we review the progress in developing new zzso drugs for personalized zzso 

